Dr. Granton is a staff physician at UHN, serving on the multi-disciplinary intensive care intensive care unit at the Toronto General Hosptial that specializes in the management of organ transplant recipients, advanced respiratory failure and sepsis, and supports advanced medical and surgical programmes.He is also Director of the Pulmonary Hypertension programme at the Toronto General Hospital and conducts research through TGHRI. Dr. Granton's clinical research focuses on lung injury, shock, thrombosis, and pulmonary vascular disease.
Specific research interests include:
- Pulmonary hypertension
- Congenital heart disease
- Exercise testing
- Heart-lung interactions
Cardiovasc Res. 2018 Jun 06;:
Rheum Dis Clin North Am. 2018 May;44(2):361-370
Rheum Dis Clin North Am. 2018 May;44(2):203-213
Chest. 2017 Dec 15;:
The feasibility of assessing swallowing physiology following prolonged intubation after cardiovascular surgery.
Pilot Feasibility Stud. 2017;3:62
Semin Respir Crit Care Med. 2017 Oct;38(5):701-710
Quality of Life, Dyspnea and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study.
Am J Med. 2017 Apr 08;:
N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.
Thromb Res. 2017 Mar 08;153:47-49
Can Respir J. 2017;2017:6736239
Clinical Researcher, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Medicine, University of Toronto